Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

✍ Scribed by John A Dormandy; Bernard Charbonnel; David JA Eckland; Erland Erdmann; Massimo Massi-Benedetti; Ian K Moules; Allan M Skene; Meng H Tan; Pierre J Lefèbvre; Gordon D Murray; Eberhard Standl; Robert G Wilcox; Lars Wilhelmsen; John Betteridge; Kåre Birkeland; Alain Golay; Robert J Heine; László Korányi; Markku Laakso; Marián Mokáň; Antanas Norkus; Valdis Pirags; Toomas Podar; André Scheen; Werner Scherbaum; Guntram Schernthaner; Ole Schmitz; Jan Škrha; Ulf Smith; Jan Tatoň

• Book ID: 117290364
• Publisher: The Lancet
• Year: 2005
• Tongue: English
• Weight: 165 KB
• Volume: 366
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/s0140-6736(05)67528-9